| Inhaled antibiotics for gram-negative respiratory infections E Wenzler, DR Fraidenburg, T Scardina, LH Danziger Clinical microbiology reviews 29 (3), 581-632, 2016 | 145 | 2016 |
| Meropenem-RPX7009 concentrations in plasma, epithelial lining fluid, and alveolar macrophages of healthy adult subjects E Wenzler, MH Gotfried, JS Loutit, S Durso, DC Griffith, MN Dudley, ... Antimicrobial agents and chemotherapy 59 (12), 7232-7239, 2015 | 103 | 2015 |
| Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens E Wenzler, MF Deraedt, AT Harrington, LH Danizger Diagnostic Microbiology and Infectious Disease 88 (4), 352-354, 2017 | 95 | 2017 |
| Searching for the Optimal Treatment for Metallo-and Serine-β-Lactamase Producing Enterobacteriaceae: Aztreonam in Combination with Ceftazidime-avibactam or Meropenem-vaborbactam. M Biagi, T Wu, M Lee, S Patel, D Butler, E Wenzler Antimicrobial agents and chemotherapy, AAC. 01426-19, 2019 | 89 | 2019 |
| Severe sepsis secondary to persistent Lysinibacillus sphaericus, Lysinibacillus fusiformis and Paenibacillus amylolyticus bacteremia E Wenzler, K Kamboj, JM Balada-Llasat International Journal of Infectious Diseases 35, 93-95, 2015 | 83 | 2015 |
| Therapeutic options for metallo-β-lactamase-producing enterobacterales X Tan, HS Kim, K Baugh, Y Huang, N Kadiyala, M Wences, N Singh, ... Infection and drug resistance, 125-142, 2021 | 73 | 2021 |
| An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia E Wenzler, F Wang, DA Goff, B Prier, J Mellett, JE Mangino, KA Bauer Clinical Infectious Diseases 65 (2), 194-200, 2017 | 71 | 2017 |
| Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat DA Butler, M Biagi, X Tan, S Qasmieh, ZP Bulman, E Wenzler Current infectious disease reports 21, 1-17, 2019 | 68 | 2019 |
| Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial … E Wenzler, DA Goff, JE Mangino, EE Reed, A Wehr, KA Bauer Diagnostic microbiology and infectious disease 84 (1), 63-68, 2016 | 62 | 2016 |
| Activity of potential alternative treatment agents for Stenotrophomonas maltophilia isolates nonsusceptible to levofloxacin and/or trimethoprim-sulfamethoxazole M Biagi, X Tan, T Wu, M Jurkovic, A Vialichka, K Meyer, RE Mendes, ... Journal of clinical microbiology 58 (2), 10.1128/jcm. 01603-19, 2020 | 57 | 2020 |
| Pharmacokinetics, safety, and tolerability of single-dose intravenous (ZTI-01) and oral fosfomycin in healthy volunteers E Wenzler, EJ Ellis-Grosse, KA Rodvold Antimicrobial Agents and Chemotherapy 61 (9), 10.1128/aac. 00775-17, 2017 | 55 | 2017 |
| Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas … M Biagi, A Vialichka, M Jurkovic, T Wu, A Shajee, M Lee, S Patel, ... Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 00559-20, 2020 | 49 | 2020 |
| Pharmacokinetics and dialytic clearance of ceftazidime-avibactam in a critically ill patient on continuous venovenous hemofiltration E Wenzler, KL Bunnell, SC Bleasdale, S Benken, LH Danziger, ... Antimicrobial Agents and Chemotherapy 61 (7), 10.1128/aac. 00464-17, 2017 | 47 | 2017 |
| Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection KA Bauer, JEW Johnston, E Wenzler, DA Goff, CH Cook, ... Anaerobe 48, 1-6, 2017 | 46 | 2017 |
| Activity of aztreonam in combination with ceftazidime–avibactam against serine-and metallo-β-lactamase–producing Pseudomonas aeruginosa M Lee, T Abbey, M Biagi, E Wenzler Diagnostic microbiology and infectious disease 99 (1), 115227, 2021 | 39 | 2021 |
| An appraisal of the pharmacokinetic and pharmacodynamic properties of meropenem-vaborbactam E Wenzler, PJ Scoble Infectious Diseases and Therapy 9 (4), 769-784, 2020 | 32 | 2020 |
| Activity of aztreonam in combination with avibactam, clavulanate, relebactam, and vaborbactam against multidrug-resistant Stenotrophomonas maltophilia M Biagi, D Lamm, K Meyer, A Vialichka, M Jurkovic, S Patel, RE Mendes, ... Antimicrobial Agents and Chemotherapy 64 (12), 10.1128/aac. 00297-20, 2020 | 31 | 2020 |
| Implementation and optimization of molecular rapid diagnostic tests for bloodstream infections E Wenzler, TT Timbrook, JR Wong, JM Hurst, SH MacVane The Bulletin of the American Society of Hospital Pharmacists 75 (16), 1191-1202, 2018 | 31 | 2018 |
| Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections E Wenzler, DA Goff, R Humphries, EJC Goldstein Infectious Diseases and Therapy 6, 149-172, 2017 | 31 | 2017 |
| Telavancin: the long and winding road from discovery to food and drug administration approvals and future directions E Wenzler, KA Rodvold Clinical Infectious Diseases 61 (suppl_2), S38-S47, 2015 | 31 | 2015 |
